novartis glp-1 receptor agonist GLP1 Agonists—Effects beyond Obesity and Diabetes novartis glp-1 receptor agonist weight
Description
This approach may be especially useful for substances that gain rapid popularity online, including products sold in less regulated markets such as injectable peptides
Wegovy contains semaglutide and received FDA approval in 2021 for chronic weight management
Nausea: Both GLP-1 medications and, less commonly, HRT can cause nausea
Curr Diabetes Rep 7:340347
doi: 10.1111/j.1464-5491.2008.02484.x
Your healthcare provider should check your thyroid function 6-8 weeks after starting or adjusting GLP-1 therapy and after significant weight loss
